Methods of inhibiting solid tumor growth by administering GPR49 antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 29, 2015
Grant Date -
Feb 5, 2015
app pub date -
Oct 31, 2012
filing date -
Nov 1, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Described herein are antibodies against GPR49 and uses of such antibodies. Various aspects relate to monoclonal, humanized, or fully human antibodies against GPR49, hybridomas or other cell lines expressing such antibodies, nucleic acids and vectors comprising nucleic acids encoding for such antibodies, and methods of treating cancer with such antibodies.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully